Chemoinformaics analysis of N-METHYL-3-CYANOPYRIDONE
Molecular Weight | 134.138 | nRot | 0 |
Heavy Atom Molecular Weight | 128.09 | nRig | 8 |
Exact Molecular Weight | 134.048 | nRing | 1 |
Solubility: LogS | -1.057 | nHRing | 1 |
Solubility: LogP | 0.052 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 18.6928 |
nHD | 0 | BPOL | 9.16724 |
QED | 0.51 |
Synth | 2.4 |
Natural Product Likeliness | -1.81 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.537 |
MDCK | 0.0000342 |
BBB | 0.525 |
PPB | 0.290866 |
VDSS | 0.802 |
FU | 0.695529 |
CYP1A2-inh | 0.397 |
CYP1A2-sub | 0.893 |
CYP2c19-inh | 0.098 |
CYP2c19-sub | 0.252 |
CYP2c9-inh | 0.026 |
CYP2c9-sub | 0.539 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.435 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.407 |
CL | 6.724 |
T12 | 0.832 |
hERG | 0.014 |
Ames | 0.247 |
ROA | 0.826 |
SkinSen | 0.185 |
Carcinogencity | 0.75 |
EI | 0.94 |
Respiratory | 0.083 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.817585 |